Pascal Soriot has experience in science and medicine, as well as the international pharmaceutical industry.
Mr Soriot has been the chief executive of AstraZeneca, a biopharmaceutical company since 2012. Prior to that, he was the chief operating officer of Roche's pharmaceuticals division; chief executive of biologics business Genentech; and held various senior pharmaceutical management roles in France, Switzerland, Japan, Australia and the US.